Our Interviews, Blogs & OpEds | Page 14 of 18 | National Center for Health Research

October Surprise

Huffington Post, October 2, 2013. What the government shutdown and Obamacare really all about?

Letter to the Editor: Still Working to Understand Cancer

The Washington Post, August 5, 2013. The Post article on the overdiagnosis of cancer clearly reported the need to reduce patients’ fear and confusion about “cancers” that many experts now agree are not really cancer, because they don’t spread and aren’t harmful. The major obstacle has been uncertainty about how likely these conditions are to predict cancer or change into an invasive cancer in the future.

The REAL Threat to Women’s Health

July 30, 2013. Given the higher death rate from cosmetic surgery and the much larger number of women undergoing cosmetic surgeries and procedures, why is it that the legislators in Texas, Virginia, Alabama, Mississippi, North Dakota, and so many other states are so concerned about the safety of abortion clinics?

FDA Panels: Too Many Conflicts or Too Little Expertise?

Pharmalive.com, June 12, 2013. Should FDA Advisory Committee members be allowed to have financial conflicts of interest regarding the approval of medical products? Diana Zuckerman discusses how financial ties to pharmaceutical companies can influence the voting and discussion on drug and medical device approvals, and how misunderstandings of statistics and the value of clinical trials can lead to the approval of dangerous products.

Angelina Jolie’s Decision

Huffington Post, May 16, 2013. Let’s use Angelina Jolie’s announcement to have a frank discussion of the treatment choices for breast cancer and to encourage women to make decisions based on their own situations not on the choice of a celebrity, however admirable she is.